ADVB - Advanced Biomed Quarterly EPS earnings growth
Advanced Biomed Inc (ADVB) is recruiting technical specialists to develop early tumor detection systems. Diversified supply channels ensure the stability of diagnostic microchip deliveries. A scientific approach and bonus programs help retain leading biologists. Analyzing the chart on GURU.Markets, we find that the quarterly EPS trend resulted in a figure that settled at -1139.40.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_ADVB_-_Advanced-Biomed-Inc_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "Advanced Biomed Inc (ADVB): Quarterly EPS earnings growth from 03/07/2025 to 11/10/2026 | 👁️GURU.Markets👁️")
Financial and market metric breakdowns for Advanced Biomed Inc (ADVB)
- market value and analyst target forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Total Debt to Equity Ratio Advanced Biomed Inc|ADVB - Long-Term Debt to Equity|Short-Term Debt to Capital advanbiomed.com|ADVB - Company Aggregate Debts|Debt to Book Capitalization Ratio Advanced Biomed Corp|ADVB - Company Long-Term Indebtedness|Company Short-Term Debts Advanced Biomed|Quick Ratio advanbiomed.com
- earnings and valuation multiples indicators:
ADVB - Company Net Income|Projected Future Earnings Advanced Biomed Inc|ADVB - Price to Earnings Multiple|Projected Price to Earnings advanbiomed.com|ADVB - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Advanced Biomed Corp|ADVB - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Advanced Biomed|ADVB - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months advanbiomed.com|ADVB - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Advanced Biomed Inc
Initial company analysis:Advanced Biomed Inc
By expanding rapid cancer screening through laboratory partnerships and microfluidic chips, Advanced Biomed Inc (ADVB) directly impacts its market capitalization through operational efficiency. By analyzing the quarterly change in EPS, an investor assesses the net profit per share trend, which allows for the mathematical confirmation of the business's financial stability and the determination of the asset's real liquidity buffer, excluding subjective market expectations.
Key competitors
BeiGene (ONC) - Year-over-year earnings per share growth for the last twelve months|Halozyme Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|RVMD (RevMed) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ascentage Pharma Corp AAPG|Quarterly EPS earnings growth CGON|Quarterly EPS earnings growth urogen.com (URGN)|Quarterly EPS earnings growth BCAX (Bicara Therapeutics)|PSNL: Year-over-year earnings per share growth for the last 12 months|ERAS: Year-over-year net earnings per share growth for the last 12 months|DCTH: Year-over-year earnings per share growth for the last twelve months|YMAB: Quarterly EPS earnings growth|aurabiosciences.com (AURA) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Candel Therapeutics Inc.|Year-over-year earnings per share growth for the last 12 months ARAY (Accuray Inc)|Quarterly EPS earnings growth SLS|Year-over-year net earnings per share growth for the last 12 months Actuate Therapeutics Inc ACTU|Quarterly EPS earnings growth CTOR (Citius Oncology, Inc.)|TuHURA Biosciences Inc. (HURA) - Earnings per share growth in annualized terms for the last twelve months|Protara Therapeutics, Inc. - Quarterly EPS earnings growth|FATE (Fate Therapeutics Inc) - Year-over-year earnings per share growth for the last 12 months|WHWK (aadibio.com) - Year-over-year net earnings per share growth for the last 12 months|TScan Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|CSBR (Champions Oncology Inc) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months XBIT|Quarterly EPS earnings growth CVM|Year-over-year net earnings per share change for the last twelve months OS Therapies Inc.|Year-over-year earnings per share growth for the last twelve months Radiopharm Theranostics RADX|Artiva Biotherapeutics Inc. (ARTV) - Earnings per share growth in annualized terms for the last twelve months|ANL - Year-over-year earnings per share growth for the last twelve months|verupharma.com (VERU) - Year-over-year net earnings per share growth for the last 12 months|TPST: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Xilio Therapeutics (XLO)|RENB (Renovaro Biosciences) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months MURA (Mural Bio)|Year-over-year net earnings per share growth for the last 12 months KAPA (Kairos Pharma Ltd)|OKUR (onkuretherapeutics.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth GDTC (CytoMed Therapeutics Limited)|Year-over-year net earnings per share change for the last twelve months Curis Inc. (CRIS)|APLM - Year-over-year earnings per share growth for the last twelve months|THAR (Tharimmune Corporation) - Year-over-year earnings per share growth for the last 12 months|GNPX: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Calidi Biotherapeutics, Inc.|SBFM (Sunshine Biopharma) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Xenetic Bio|Quarterly EPS earnings growth SLRX|Kitov Pharma - Year-over-year earnings per share growth for the last 12 months|American Oncology Network, Inc. - Year-over-year net earnings per share growth for the last 12 months|beigene.com - Year-over-year earnings per share growth for the last twelve months|Checkpoint Therapeutics, Inc. - Quarterly EPS earnings growth|ELEV: Year-over-year earnings per share growth for the last twelve months|ICAD: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Ikena Oncology|NTBL (Notable Labs, Ltd.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Viracta|Year-over-year earnings per share growth for the last twelve months MorphoSys (MOR)|NAYA Biosciences Inc - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth AAPGV (Ascentage Pharma Group Ltd)
